SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-038478
Filing Date
2024-03-25
Accepted
2024-03-25 16:56:27
Documents
17
Period of Report
2024-03-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm249556d1_8k.htm   iXBRL 8-K 30920
2 EXHIBIT 99.1 tm249556d1_ex99-1.htm EX-99.1 13447
3 EXHIBIT 10.1 tm249556d1_ex10-1.htm EX-10.1 247514
7 GRAPHIC tm249556d1_ex99-1img1.jpg GRAPHIC 2649
8 GRAPHIC tm249556d1_ex10-1img001.jpg GRAPHIC 1419
  Complete submission text file 0001104659-24-038478.txt   525070

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA uthr-20240325.xsd EX-101.SCH 3012
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE uthr-20240325_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE uthr-20240325_pre.xml EX-101.PRE 22357
20 EXTRACTED XBRL INSTANCE DOCUMENT tm249556d1_8k_htm.xml XML 3508
Mailing Address 1000 SPRING ST SILVER SPRING MD 20910
Business Address 1000 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26301 | Film No.: 24779966
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)